Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the company’s discovery platform transforms drug development from an iterative search process into a data-driven design model.
Jonathan Steckbeck
Advertisement
Articles by Jonathan Steckbeck
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Impact will TrumpRx and Other DTC Programs Have on Drug Availability?
2
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
3
Roundup: Biopharma Funding Rounds Advance Clinical Development of Novel Therapy and Treatment Solutions
4
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
5
